复方赖诺普利片治疗轻、中度原发性高血压病24h动态血压监测的有效性及安全性试验
[Translation] Efficacy and safety of 24-hour dynamic blood pressure monitoring in the treatment of mild and moderate essential hypertension with compound lisinopril tablets
应用24h动态血压监测(ABPM),评价四川尚锐生物医药有限公司研发的复方赖诺普利片治疗轻、中度原发性高血压病患者的有效性和安全性。
[Translation] To evaluate the efficacy and safety of compound lisinopril tablets developed by Sichuan Shangrui Biotechnology Co., Ltd. in the treatment of patients with mild to moderate essential hypertension using 24-h ambulatory blood pressure monitoring (ABPM).
复方赖诺普利片治疗苯磺酸氨氯地平片单药治疗未有效控制的轻、中度原发性高血压病有效性及安全性随机、双盲双模拟、阳性药、平行对照、多中心临床试验
[Translation] A randomized, double-blind, double-dummy, active-drug, parallel-controlled, multicenter clinical trial on the efficacy and safety of compound lisinopril tablets in the treatment of mild and moderate essential hypertension that is not effectively controlled by amlodipine besylate tablets alone
以苯磺酸氨氯地平片作为阳性对照,评价四川尚锐生物医药有限公司研发的复方赖诺普利片治疗轻、中度原发性高血压病患者的有效性和安全性。
[Translation] Using amlodipine besylate tablets as a positive control, the efficacy and safety of compound lisinopril tablets developed by Sichuan Shangrui Biotechnology Co., Ltd. in the treatment of patients with mild and moderate essential hypertension were evaluated.
复方赖诺普利片治疗赖诺普利片单药治疗未有效控制的轻、中度原发性高血压病有效性及安全性随机、双盲双模拟、阳性药、平行对照、多中心临床试验
[Translation] A randomized, double-blind, double-dummy, active-drug, parallel-controlled, multicenter clinical trial on the efficacy and safety of compound lisinopril tablets in the treatment of mild and moderate essential hypertension that is not effectively controlled by lisinopril tablets alone
以赖诺普利片作为阳性对照,评价四川尚锐生物医药有限公司研发的复方赖诺普利片治疗轻、中度原发性高血压病患者的有效性和安全性。
[Translation] Using lisinopril tablets as a positive control, the efficacy and safety of compound lisinopril tablets developed by Sichuan Shangrui Biotechnology Co., Ltd. in the treatment of patients with mild and moderate essential hypertension were evaluated.
100 Clinical Results associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.
0 Patents (Medical) associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.
100 Deals associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.
100 Translational Medicine associated with Sichuan Shangrui Biopharmaceutical Co., Ltd.